Paul Marshall and Ian Wace’s Top 5 Stock Picks

1. Teleflex Incorporated (NYSE:TFX)

Marshall and Wace’s Stake Value: $368,740,000
Percentage of Paul Marshall and Ian Wace’s 13F Portfolio: 1.66%
Number of Hedge Fund Holders: 30

Teleflex Incorporated (NYSE:TFX) designs, develops, manufactures, and distributes single-use medical devices for routine diagnostic and therapeutic procedures in critical care and surgical settings. The company was founded in 1943 and is placed first on the list of Paul Marshall and Ian Wace’s stock picks. Teleflex Incorporated (NYSE:TFX) shares have returned 14.41% to investors over the course of the past 12 months.

On September 7, Raymond James analyst Jayson Bedford initiated coverage of Teleflex Incorporated (NYSE:TFX) with an “Outperform” rating and set a price target at $440. On July 29, Teleflex Incorporated (NYSE:TFX) declared a quarterly dividend of $0.34 per share, in line with the previous. 

Paul Marshall and Ian Wace’s Marshall Wace LLP holds 917,743 shares in Teleflex Incorporated (NYSE:TFX), worth over $368.74 million, representing 1.66% of their portfolio. Alexander Becker’s Codex Capital is Teleflex Incorporated (NYSE:TFX) most significant stakeholder, with 11,900 shares worth $4.77 billion.

ClearBridge Investments, in its first-quarter 2021 investor letter, mentioned Teleflex Incorporated (NYSE: TFX). Here is what the fund said: 

“Teleflex is a diversified medical device company with leading market share in several low-cost consumable niche categories, creating high-margin recurring revenue streams with steady growth and pricing. Its unique UroLift product has the potential to accelerate growth of the company with its strong positioning as the only minimally invasive product to treat BPH in the prostate gland with no side effects, a treatment area with a large total addressable market.”

You can also take a peek at Billionaire James Dinan’s Top 10 Stock Picks and Billionaire Ken Fisher’s Top 10 High Dividend Stock Picks